In addition, a reduction in Src activity, a tyrosine protein kinase, which activates the PI3K/Akt pathway, leads to inhibition of tumor cell proliferation and metastasis in SW48 and HT-29 colon cancer cell lines [84]. This evidence concerns the gene AKT1 and colonic neoplasm.